
Insurance Companies Must Cover Test for BRCA, the “Breast Cancer Gene”
The Maurer Foundation applauds the inclusion of genetic testing for BRCA1 and BRCA2 under the Affordable Care Act.
The Maurer Foundation applauds the inclusion of genetic testing for BRCA1 and BRCA2 under the Affordable Care Act.
Breast cancer non-profit Maurer Foundation named recipient of Long Island health expo proceeds.
What are the BRCA1 and BRCA2 genes and how do they increase your risk of breast cancer?
On July 24th, the Mind Body Spirit Expo will bring an inspiring combination of speakers, demonstrations, and workshops to Carlyle on the Green in Farmingdale for a one-day celebration of health and wellness. All proceeds to go to The Maurer Foundation.
In response to a recent article in The New York Times Magazine, “Our Feel Good War on Breast Cancer,” Dr. Lora Weiselberg, a leading expert in breast cancer from Hofstra North Shore-LIJ School of Medicine, sets the record straight.
James Alterbaum’s extensive background in law and business make him a valuable asset to the Foundation’s Board of Directors.
Come visit the Maurer Foundation booth Thursday, May 23rd, at Long Island’s largest business-to-business event, the Hauppauge Industrial Association-Long Island (HIA-LI) Annual Trade Show and Conference.
Definition, treatment, survival rates, prognosis and statistics of triple negative breast cancer.
The researchers found that women with implants had a 26% higher risk of being diagnosed at a later stage of breast cancer than those without, coupled with a 38% higher risk of death from breast cancer than those women without implants.